Trials disrupted by the first wave of the COVID-19 pandemic in 2020 are continuing to reopen, but the emergence of two more contagious variants of the SARS-CoV-2 virus resulted in a drop in the rate of recruitment in January, according to data analysis firm GlobalData. Read More
The number of clinical trials focused on COVID-19 has increased 639 percent worldwide to more than 4,000 trials in January 2021, up from 549 in early April 2020. Of those new trials, 762 are being conducted in the U.S., far outpacing other countries, according to a report by marketing research firm GlobalData. China was in a distant second place with 462 trials. Read More
Faced with evolving variants of the SARS-CoV-2 virus, COVID-19 vaccine-makers are considering tweaks to their current products that would call for only small safety-focused trials rather than entirely new phase 3 trials, and the FDA has signaled its approval of that approach. Read More
Individuals who have received one of the COVID-19 vaccines approved for emergency use by the FDA do not need to be excluded from participating in other clinical trials, the agency has said. Read More
Trials of COVID-19 vaccines, along with research into variants of the SARS-CoV-2 virus that causes the disease, will dominate the vaccine development space through 2022, with some nonCOVID vaccine trials slowly trickling back after being delayed by the pandemic. Read More
RSS
